Enko and Syngenta Advance Novel Fungicide Chemistry
First-season trials across three continents validated greenhouse results, demonstrating ENKOMPASS™’s ability to
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
![]()
Enko Chem, Inc. announced that its novel fungicide chemistry has advanced to a second year of field testing. First-season trials spanning Europe, North America and Asia demonstrated that disease control first observed in the greenhouse translated to real-world field conditions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261119480924/en/

The milestone marks an important step in Enko’s efforts to bring new modes of action to crop protection. Fungal diseases threaten crop yields worldwide, while the development of resistance to widely used fungicides continues to reduce growers’ effective disease management options. Discovering chemistry that acts on a different biological target will provide growers with a new tool to control difficult diseases and help manage resistance.
The fungicide chemistry originated through Enko’s ENKOMPASS™ discovery platform, which is designed to identify previously unexplored biological targets and discover novel molecules with the potential to address unmet needs in crop protection.
“Fungicide researchers have pursued this target for decades,” said Tony Klemm, CEO of Enko. “ENKOMPASS delivered chemistry that acts on a new target, and a full season in the field provides further confirmation. This is exactly what the platform was built to do. Advancing into a second season of field testing is an important milestone in demonstrating how our discovery approach can translate scientific breakthroughs into potential solutions for growers.”
Field testing was conducted in collaboration with Syngenta Crop Protection, which evaluated leading compounds under a range of growing conditions.
The first-season findings build on promising greenhouse results and provide an encouraging foundation for continued development. Demonstrating disease control across multiple geographies and under real-world conditions represents an important step in evaluating the chemistry’s potential.
A second season of field trials will build on the initial findings. The additional data will help inform decisions about the chemistry’s potential development and advancement toward a new fungicide option for growers.
About Enko Chem, Inc.
Enko Chem, Inc. designs safe and sustainable solutions to farmers’ biggest crop threats today, from pest resistance to new diseases. By applying the latest drug discovery and development approaches from pharma to plants, Enko is bringing an innovation model to agriculture and meeting farmers’ evolving needs. Founded in 2017, and led by a team of proven scientists, entrepreneurs, and agriculture industry veterans, Enko is backed by investors including the Gates Foundation, Anterra Capital, DYDX Capital, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food, and Rabo Food & Agri Innovation Fund. Enko is headquartered in Mystic, Connecticut, USA. For more information, visit enko.ag. Follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261119480924/en/
Media gallery

